Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
10 Years to 65 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Age > or equal 10 years and < 65 years
Impaired visual acuity in affected eyes due to LHON: Visual acuity in best eye >0.4 logMAR
No explanation for visual loss besides LHON
Any previous use of idebenone
Participation in another clinical trial of any investigational drug within 3 months prior to Baseline
Previous participation in Study SNT-II-003 (RHODOS) for idebenone.